[DOI] [PubMed] [Google Scholar] 20.Markovics A., Szoke ., Sndor K., Brzsei R., Bagoly T., Kemny ., Elekes K., Pintr E., Szolcsnyi J., Helyes Z
Outcome: Achieved 20/25 vision by 3 months, faster than typical recovery
PMC 1855089
While clinical trials showed statistically significant differences in cognitive outcomes between people randomized to receive lecanemab or donanemab and those randomized to receive placebo, the benefits of treatment in the short term may be imperceptible to those receiving it
doi:10.1089/acm.2010.0716 Rachel Erwin, Nutritionist & Content Writer Rachel is a Nutritionist with a BSc in Biology and Global Health from the University of Toronto, and a Postgraduate Diploma in Human Nutrition from the University of Ulster